Fiducial Markers Market by Cancer Type (Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, and Other Cancers), Product (Metal-based Markers and Other Fiducial Markers), End User (Hospitals and Outpatient, Independent Radiotherapy Centres and Cancer Research Centres), Modality (CT/CBCT, MRI, Ultrasound, and Radiotherapy) and Geography – Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026
Fiducial markers are the tiny objects placed in or near a tumor to spot the area that needs to get surgery. These markers are designed to spot the precise position of the tumor and assist the doctor in providing the radiation on that specified area because the radiation can damage the other tissues. These fiducial markers are widely used in cancer treatment, where radiotherapy is performed. Dramatically increasing cases of cancer, growing favorable reimbursements, and rapidly growing investments in the cancer research and development sector are the few significant factors that are contributing to the market growth. But somehow, the substitute therapies for radiotherapy and the expensive costs for the fiducial markers are making the market drawback. Fiducial Markers Market is predicted to grow at a CAGR of 4.90% with a market value in 2026.
Research Methodology:
The fiducial markers market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:
The Fiducial Markers market can be analyzed on the market based on:
Cancer Type:
Fiducial markers based on the product is categorized into metal-based markers and other fiducial markers. Metal-based markers are the most used markers in this process of radiotherapy, and the metal-based markers are further divided into pure gold, gold alloys, and other metal-based markers. Pure gold markers are very effective in this segment as these markers are immovable and do not react to the tissues.
As per the end-users, the fiducial markers market is separated into hospitals and outpatient, independent radiotherapy centers, and cancer research centers. The hospitals and outpatient segment is anticipated to have a major share in the market growth due to the improvised facilities in the hospitals and outpatient care. Further, the fiducial markers included in radiotherapy is a relatively less critical process, which is more suitable in outpatient care.
The ultrasound modality segment plays a major role on the basis of modality in the fiducial markers market. Because the ultrasound is the less harmful method compared to all modalities as in most cases, people prefer less invasive procedures.
As per the geography, the fiducial markers market is segregated into majorly four regions-North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share in the market because of the potential companies present in this region and in addition, the growing adoption of the latest radiotherapy treatment in the healthcare centers in North America.
In this scenario, of globally increasing prevalence of cancer is the major attribute to support market growth. The other lucrative factors contributing to the fiducial markers market growth such as, not only in developed countries but also the developing countries are concentrating on the favorable reimbursements. Nonetheless, the lack of skilled professionals in this field is a challenge for the fiducial markers market.
CIVCO RADIOTHERAPY, Boston Scientific Corporation, IZI Medical Products, IBA, Naslund Medical AB, Medtronic, Best Medical International, Inc., Nanovi A/S, Carbon Medical Technologies, Eckert & Ziegler., Innovative Oncology Solutions, QlRad Inc, Stellar Medical, JJ-Medtech, QFIX, Varian Medical Systems, Inc, Beekley Corporation, Innomedicus Ag, Meditronix Corporation and Seedos Ltd. These are the companies that are leading the market.
Therefore, the fiducial markers act as a significant role in cancer treatment. Furthermore, the stakeholders in the emerging markets are also investing heavily for the better improvement of the healthcare centers in the respective countries, thus enabling further growth in the market. The fiducial markers market report gives the PEST analysis of the regions expresses the micro-environmental factors.
Research Methodology:
The fiducial markers market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:
The Fiducial Markers market can be analyzed on the market based on:
Cancer Type:
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Gastric Cancer
- Other Cancers
- Metal-based Markers
- Pure Gold
- Gold Alloys
- Other Metal-based Markers
- Other Fiducial Markers
- Hospitals & Outpatient Facilities
- Independent Radiotherapy Centers
- Cancer Research Centers
- CT/CBCT
- MRI
- Ultrasound
- Radiotherapy
- North America
- Europe
- Asia Pacific
- Rest of the World
Fiducial markers based on the product is categorized into metal-based markers and other fiducial markers. Metal-based markers are the most used markers in this process of radiotherapy, and the metal-based markers are further divided into pure gold, gold alloys, and other metal-based markers. Pure gold markers are very effective in this segment as these markers are immovable and do not react to the tissues.
As per the end-users, the fiducial markers market is separated into hospitals and outpatient, independent radiotherapy centers, and cancer research centers. The hospitals and outpatient segment is anticipated to have a major share in the market growth due to the improvised facilities in the hospitals and outpatient care. Further, the fiducial markers included in radiotherapy is a relatively less critical process, which is more suitable in outpatient care.
The ultrasound modality segment plays a major role on the basis of modality in the fiducial markers market. Because the ultrasound is the less harmful method compared to all modalities as in most cases, people prefer less invasive procedures.
As per the geography, the fiducial markers market is segregated into majorly four regions-North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share in the market because of the potential companies present in this region and in addition, the growing adoption of the latest radiotherapy treatment in the healthcare centers in North America.
In this scenario, of globally increasing prevalence of cancer is the major attribute to support market growth. The other lucrative factors contributing to the fiducial markers market growth such as, not only in developed countries but also the developing countries are concentrating on the favorable reimbursements. Nonetheless, the lack of skilled professionals in this field is a challenge for the fiducial markers market.
CIVCO RADIOTHERAPY, Boston Scientific Corporation, IZI Medical Products, IBA, Naslund Medical AB, Medtronic, Best Medical International, Inc., Nanovi A/S, Carbon Medical Technologies, Eckert & Ziegler., Innovative Oncology Solutions, QlRad Inc, Stellar Medical, JJ-Medtech, QFIX, Varian Medical Systems, Inc, Beekley Corporation, Innomedicus Ag, Meditronix Corporation and Seedos Ltd. These are the companies that are leading the market.
Therefore, the fiducial markers act as a significant role in cancer treatment. Furthermore, the stakeholders in the emerging markets are also investing heavily for the better improvement of the healthcare centers in the respective countries, thus enabling further growth in the market. The fiducial markers market report gives the PEST analysis of the regions expresses the micro-environmental factors.
- The report presents an inclusive analysis of the fiducial markers market lucrative factors, hindering factors, and challenges.
- The report further presents the simulative strategies of the key market companies in terms of mergers, partnerships, and innovations.
- The report also assists the research and development industry of fiducial markers market for innovation analysis.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. CANCER TYPE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Prostate Cancer
5.3. Lung Cancer
5.4. Breast Cancer
5.5. Gastric Cancer
5.6. Other Cancers
6. PRODUCT: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Metal-based Markers
6.2.1. Pure Gold
6.2.2. Gold Alloys
6.2.3. Other Metal-based Markers
6.3. Other Fiducial Markers
7. END-USER: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Hospitals & Outpatient Facilities
7.3. Independent Radiotherapy Centers
7.4. Cancer Research Centers
8. MODALITY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. CT/CBCT
8.3. MRI
8.4. Ultrasound
8.5. Radiotherapy
9. GEOGRAPHY: MARKET SIZE & ANALYSIS
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World
10. COMPETITIVE LANDSCAPE
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.3. Mergers and Acquisitions, Legal, Awards, Partnerships
10.4. Product Launches and execution
11. VENDOR PROFILES
11.1. CIVCO RADIOTHERAPY
11.1.1. Overview
11.1.2. Product Offerings
11.1.3. Geographic Revenue
11.1.4. Business Units
11.1.5. Developments
11.1.6. Business Strategy
11.2. Boston Scientific Corporation
11.2.1. Overview
11.2.2. Product Offerings
11.2.3. Geographic Revenue
11.2.4. Business Units
11.2.5. Developments
11.2.6. Business Strategy
11.3. IZI Medical Products
11.3.1. Overview
11.3.2. Product Offerings
11.3.3. Geographic Revenue
11.3.4. Business Units
11.3.5. Developments
11.3.6. Business Strategy
11.4. IBA
11.4.1. Overview
11.4.2. Product Offerings
11.4.3. Geographic Revenue
11.4.4. Business Units
11.4.5. Developments
11.4.6. Business Strategy
11.5. Naslund Medical AB.
11.5.1. Overview
11.5.2. Product Offerings
11.5.3. Geographic Revenue
11.5.4. Business Units
11.5.5. Developments
11.5.6. Business Strategy
11.6. Medtronic
11.6.1. Overview
11.6.2. Product Offerings
11.6.3. Geographic Revenue
11.6.4. Business Units
11.6.5. Developments
11.6.6. Business Strategy
11.7. Best Medical International, Inc
11.7.1. Overview
11.7.2. Product Offerings
11.7.3. Geographic Revenue
11.7.4. Business Units
11.7.5. Developments
11.7.6. Business Strategy
11.8. Nanovi A/S
11.8.1. Overview
11.8.2. Product Offerings
11.8.3. Geographic Revenue
11.8.4. Business Units
11.8.5. Developments
11.8.6. Business Strategy
11.9. Carbon Medical Technologies
11.9.1. Overview
11.9.2. Product Offerings
11.9.3. Geographic Revenue
11.9.4. Business Units
11.9.5. Developments
11.9.6. Business Strategy
11.10. Eckert & Ziegler
11.10.1. Overview
11.10.2. Product Offerings
11.10.3. Geographic Revenue
11.10.4. Business Units
11.10.5. Developments
11.10.6. Business Strategy
12. COMPANIES TO WATCH
12.1. Innovative Oncology Solutions.
12.1.1. Overview
12.1.2. Market
12.1.3. Business Strategy
12.2. QlRad Inc
12.2.1. Overview
12.2.2. Market
12.2.3. Business Strategy
12.3. Stellar Medical.
12.3.1. Overview
12.3.2. Market
12.3.3. Business Strategy
12.4. JJ-Medtech
12.4.1. Overview
12.4.2. Market
12.4.3. Business Strategy
12.5 Innovative Oncology Solutions.
12.5.1 Overview
12.5.2 Market
12.5.3 Business Strategy
13. ANALYST OPINION
14. ANNEXURE
14.1. Report Scope
14.2. Market Definitions
14.3. Research Methodology
14.3.1. Data Collation and In-house Estimation
14.3.2. Market Triangulation
14.3.3. Forecasting
15. REPORT ASSUMPTIONS
16. DECLARATIONS
17. STAKEHOLDERS
18. ABBREVIATIONS
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. CANCER TYPE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Prostate Cancer
5.3. Lung Cancer
5.4. Breast Cancer
5.5. Gastric Cancer
5.6. Other Cancers
6. PRODUCT: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Metal-based Markers
6.2.1. Pure Gold
6.2.2. Gold Alloys
6.2.3. Other Metal-based Markers
6.3. Other Fiducial Markers
7. END-USER: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Hospitals & Outpatient Facilities
7.3. Independent Radiotherapy Centers
7.4. Cancer Research Centers
8. MODALITY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. CT/CBCT
8.3. MRI
8.4. Ultrasound
8.5. Radiotherapy
9. GEOGRAPHY: MARKET SIZE & ANALYSIS
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World
10. COMPETITIVE LANDSCAPE
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.3. Mergers and Acquisitions, Legal, Awards, Partnerships
10.4. Product Launches and execution
11. VENDOR PROFILES
11.1. CIVCO RADIOTHERAPY
11.1.1. Overview
11.1.2. Product Offerings
11.1.3. Geographic Revenue
11.1.4. Business Units
11.1.5. Developments
11.1.6. Business Strategy
11.2. Boston Scientific Corporation
11.2.1. Overview
11.2.2. Product Offerings
11.2.3. Geographic Revenue
11.2.4. Business Units
11.2.5. Developments
11.2.6. Business Strategy
11.3. IZI Medical Products
11.3.1. Overview
11.3.2. Product Offerings
11.3.3. Geographic Revenue
11.3.4. Business Units
11.3.5. Developments
11.3.6. Business Strategy
11.4. IBA
11.4.1. Overview
11.4.2. Product Offerings
11.4.3. Geographic Revenue
11.4.4. Business Units
11.4.5. Developments
11.4.6. Business Strategy
11.5. Naslund Medical AB.
11.5.1. Overview
11.5.2. Product Offerings
11.5.3. Geographic Revenue
11.5.4. Business Units
11.5.5. Developments
11.5.6. Business Strategy
11.6. Medtronic
11.6.1. Overview
11.6.2. Product Offerings
11.6.3. Geographic Revenue
11.6.4. Business Units
11.6.5. Developments
11.6.6. Business Strategy
11.7. Best Medical International, Inc
11.7.1. Overview
11.7.2. Product Offerings
11.7.3. Geographic Revenue
11.7.4. Business Units
11.7.5. Developments
11.7.6. Business Strategy
11.8. Nanovi A/S
11.8.1. Overview
11.8.2. Product Offerings
11.8.3. Geographic Revenue
11.8.4. Business Units
11.8.5. Developments
11.8.6. Business Strategy
11.9. Carbon Medical Technologies
11.9.1. Overview
11.9.2. Product Offerings
11.9.3. Geographic Revenue
11.9.4. Business Units
11.9.5. Developments
11.9.6. Business Strategy
11.10. Eckert & Ziegler
11.10.1. Overview
11.10.2. Product Offerings
11.10.3. Geographic Revenue
11.10.4. Business Units
11.10.5. Developments
11.10.6. Business Strategy
12. COMPANIES TO WATCH
12.1. Innovative Oncology Solutions.
12.1.1. Overview
12.1.2. Market
12.1.3. Business Strategy
12.2. QlRad Inc
12.2.1. Overview
12.2.2. Market
12.2.3. Business Strategy
12.3. Stellar Medical.
12.3.1. Overview
12.3.2. Market
12.3.3. Business Strategy
12.4. JJ-Medtech
12.4.1. Overview
12.4.2. Market
12.4.3. Business Strategy
12.5 Innovative Oncology Solutions.
12.5.1 Overview
12.5.2 Market
12.5.3 Business Strategy
13. ANALYST OPINION
14. ANNEXURE
14.1. Report Scope
14.2. Market Definitions
14.3. Research Methodology
14.3.1. Data Collation and In-house Estimation
14.3.2. Market Triangulation
14.3.3. Forecasting
15. REPORT ASSUMPTIONS
16. DECLARATIONS
17. STAKEHOLDERS
18. ABBREVIATIONS
LIST OF TABLES
TABLE 1. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 2. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR PROSTATE CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 3. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR LUNG CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 4. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR BREAST CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 5. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR GASTRIC CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 6. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR OTHER CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 7. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 8. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR PURE GOLD, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 9. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR METAL-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 10. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR GOLD ALLOYS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 11. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR POLYMER-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 12. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR OTHER METAL-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 13. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 14. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR HOSPITALS & OUTPATIENT FACILITIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 15. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR INDEPENDENT RADIOTHERAPY CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 16. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR CANCER RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 17. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 18. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR CT/CBCT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 19. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR MRI, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 20. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR ULTRASOUND, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 21. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR RADIOTHERAPY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 22. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY REGION, 2020-2026 (USD MILLION)
TABLE 23. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 24. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 25. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 26. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 27. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 28. U.S. FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 29. CANADA CANADA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 30. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 31. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 32. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 33. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 34. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 35. GERMANY FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 36. UK FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 37. FRANCE FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 38. ITALY FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 39. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 40. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 41. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 42. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 43. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 44. CHINA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 45. INDIA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 46. JAPAN PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 47. AUSTRALIA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 48. REST OF ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 49. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 50. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 51. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 52. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 53. CIVCO RADIOTHERAPY: OVERVIEW
TABLE 54. CIVCO RADIOTHERAPY: STRATEGIC SNAPSHOT
TABLE 55. CIVCO RADIOTHERAPY: BUSINESS FOCUS
TABLE 56. CIVCO RADIOTHERAPY: END USER/SERVICE PORTFOLIO
TABLE 57. BOSTON SCIENTIFIC CORPORATION: OVERVIEW
TABLE 58. BOSTON SCIENTIFIC CORPORATION: STRATEGIC SNAPSHOT
TABLE 59. BOSTON SCIENTIFIC CORPORATION: BUSINESS FOCUS
TABLE 60. BOSTON SCIENTIFIC CORPORATION: END USER/SERVICE PORTFOLIO
TABLE 61. IZI MEDICAL PRODUCTS : OVERVIEW
TABLE 62. IZI MEDICAL PRODUCTS : STRATEGIC SNAPSHOT
TABLE 63. IZI MEDICAL PRODUCTS : BUSINESS FOCUS
TABLE 64. IZI MEDICAL PRODUCTS : END USER/SERVICE PORTFOLIO
TABLE 65. IBA : OVERVIEW
TABLE 66. IBA : STRATEGIC SNAPSHOT
TABLE 67. IBA : BUSINESS FOCUS
TABLE 68. IBA : END USER/SERVICE PORTFOLIO
TABLE 69. NASLUND MEDICAL AB : OVERVIEW
TABLE 70. NASLUND MEDICAL AB : STRATEGIC SNAPSHOT
TABLE 71. NASLUND MEDICAL AB : BUSINESS FOCUS
TABLE 72. NASLUND MEDICAL AB : END USER/SERVICE PORTFOLIO
TABLE 73. CHOICESPINE: OVERVIEW
TABLE 74. CHOICESPINE: STRATEGIC SNAPSHOT
TABLE 75. CHOICESPINE: BUSINESS FOCUS
TABLE 76. CHOICESPINE: END USER/SERVICE PORTFOLIO
TABLE 77. BEST MEDICAL INTERNATIONAL, INC.: OVERVIEW
TABLE 78. BEST MEDICAL INTERNATIONAL, INC.: STRATEGIC SNAPSHOT
TABLE 79. BEST MEDICAL INTERNATIONAL, INC.: BUSINESS FOCUS
TABLE 80. BEST MEDICAL INTERNATIONAL, INC.: END USER/SERVICE PORTFOLIO
TABLE 81. NANOVI A/S: OVERVIEW
TABLE 82. NANOVI A/S: STRATEGIC SNAPSHOT
TABLE 83. NANOVI A/S: BUSINESS FOCUS
TABLE 84. NANOVI A/S: END USER/SERVICE PORTFOLIO
TABLE 85. CARBON MEDICAL TECHNOLOGIES: OVERVIEW
TABLE 86. CARBON MEDICAL TECHNOLOGIES: STRATEGIC SNAPSHOT
TABLE 87. CARBON MEDICAL TECHNOLOGIES: BUSINESS FOCUS
TABLE 88. CARBON MEDICAL TECHNOLOGIES: END USER/SERVICE PORTFOLIO
TABLE 89. ECKERT & ZIEGLER.: OVERVIEW
TABLE 90. ECKERT & ZIEGLER. : STRATEGIC SNAPSHOT
TABLE 91. ECKERT & ZIEGLER.: BUSINESS FOCUS
TABLE 92. ECKERT & ZIEGLER.: END USER/SERVICE PORTFOLIO
TABLE 1. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 2. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR PROSTATE CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 3. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR LUNG CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 4. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR BREAST CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 5. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR GASTRIC CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 6. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR OTHER CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 7. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 8. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR PURE GOLD, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 9. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR METAL-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 10. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR GOLD ALLOYS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 11. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR POLYMER-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 12. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR OTHER METAL-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 13. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 14. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR HOSPITALS & OUTPATIENT FACILITIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 15. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR INDEPENDENT RADIOTHERAPY CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 16. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR CANCER RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 17. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 18. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR CT/CBCT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 19. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR MRI, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 20. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR ULTRASOUND, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 21. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR RADIOTHERAPY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 22. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY REGION, 2020-2026 (USD MILLION)
TABLE 23. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 24. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 25. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 26. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 27. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 28. U.S. FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 29. CANADA CANADA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 30. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 31. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 32. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 33. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 34. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 35. GERMANY FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 36. UK FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 37. FRANCE FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 38. ITALY FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 39. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 40. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 41. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 42. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 43. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 44. CHINA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 45. INDIA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 46. JAPAN PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 47. AUSTRALIA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 48. REST OF ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 49. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
TABLE 50. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 51. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
TABLE 52. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
TABLE 53. CIVCO RADIOTHERAPY: OVERVIEW
TABLE 54. CIVCO RADIOTHERAPY: STRATEGIC SNAPSHOT
TABLE 55. CIVCO RADIOTHERAPY: BUSINESS FOCUS
TABLE 56. CIVCO RADIOTHERAPY: END USER/SERVICE PORTFOLIO
TABLE 57. BOSTON SCIENTIFIC CORPORATION: OVERVIEW
TABLE 58. BOSTON SCIENTIFIC CORPORATION: STRATEGIC SNAPSHOT
TABLE 59. BOSTON SCIENTIFIC CORPORATION: BUSINESS FOCUS
TABLE 60. BOSTON SCIENTIFIC CORPORATION: END USER/SERVICE PORTFOLIO
TABLE 61. IZI MEDICAL PRODUCTS : OVERVIEW
TABLE 62. IZI MEDICAL PRODUCTS : STRATEGIC SNAPSHOT
TABLE 63. IZI MEDICAL PRODUCTS : BUSINESS FOCUS
TABLE 64. IZI MEDICAL PRODUCTS : END USER/SERVICE PORTFOLIO
TABLE 65. IBA : OVERVIEW
TABLE 66. IBA : STRATEGIC SNAPSHOT
TABLE 67. IBA : BUSINESS FOCUS
TABLE 68. IBA : END USER/SERVICE PORTFOLIO
TABLE 69. NASLUND MEDICAL AB : OVERVIEW
TABLE 70. NASLUND MEDICAL AB : STRATEGIC SNAPSHOT
TABLE 71. NASLUND MEDICAL AB : BUSINESS FOCUS
TABLE 72. NASLUND MEDICAL AB : END USER/SERVICE PORTFOLIO
TABLE 73. CHOICESPINE: OVERVIEW
TABLE 74. CHOICESPINE: STRATEGIC SNAPSHOT
TABLE 75. CHOICESPINE: BUSINESS FOCUS
TABLE 76. CHOICESPINE: END USER/SERVICE PORTFOLIO
TABLE 77. BEST MEDICAL INTERNATIONAL, INC.: OVERVIEW
TABLE 78. BEST MEDICAL INTERNATIONAL, INC.: STRATEGIC SNAPSHOT
TABLE 79. BEST MEDICAL INTERNATIONAL, INC.: BUSINESS FOCUS
TABLE 80. BEST MEDICAL INTERNATIONAL, INC.: END USER/SERVICE PORTFOLIO
TABLE 81. NANOVI A/S: OVERVIEW
TABLE 82. NANOVI A/S: STRATEGIC SNAPSHOT
TABLE 83. NANOVI A/S: BUSINESS FOCUS
TABLE 84. NANOVI A/S: END USER/SERVICE PORTFOLIO
TABLE 85. CARBON MEDICAL TECHNOLOGIES: OVERVIEW
TABLE 86. CARBON MEDICAL TECHNOLOGIES: STRATEGIC SNAPSHOT
TABLE 87. CARBON MEDICAL TECHNOLOGIES: BUSINESS FOCUS
TABLE 88. CARBON MEDICAL TECHNOLOGIES: END USER/SERVICE PORTFOLIO
TABLE 89. ECKERT & ZIEGLER.: OVERVIEW
TABLE 90. ECKERT & ZIEGLER. : STRATEGIC SNAPSHOT
TABLE 91. ECKERT & ZIEGLER.: BUSINESS FOCUS
TABLE 92. ECKERT & ZIEGLER.: END USER/SERVICE PORTFOLIO
LIST OF FIGURES
CHART. 1. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 2. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR PROSTATE CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 3. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR LUNG CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 4. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR BREAST CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 5. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR GASTRIC CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 6. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR OTHER CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 7. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 8. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR PURE GOLD, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 9. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR METAL-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 10. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR GOLD ALLOYS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 11. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR POLYMER-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 12. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR OTHER METAL-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 13. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 14. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR HOSPITALS & OUTPATIENT FACILITIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 15. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR INDEPENDENT RADIOTHERAPY CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 16. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR CANCER RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 17. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 18. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR CT/CBCT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 19. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR MRI, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 20. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR ULTRASOUND, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 21. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR RADIOTHERAPY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 22. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY REGION, 2020-2026 (USD MILLION)
CHART. 23. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 24. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 25. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 26. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 27. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 28. U.S. FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 29. CANADA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 30. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 31. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 32. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 33. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 34. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 35. GERMANY FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 36. UK FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 37. FRANCE FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 38. ITALY FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 39. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 40. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 41. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 42. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 43. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 44. CHINA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 45. INDIA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 46. JAPAN PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 47. AUSTRALIA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 48. REST OF ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 49. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 50. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 51. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 52. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 1. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 2. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR PROSTATE CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 3. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR LUNG CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 4. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR BREAST CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 5. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR GASTRIC CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 6. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR OTHER CANCER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 7. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 8. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR PURE GOLD, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 9. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR METAL-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 10. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR GOLD ALLOYS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 11. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR POLYMER-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 12. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR OTHER METAL-BASED MARKERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 13. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 14. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR HOSPITALS & OUTPATIENT FACILITIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 15. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR INDEPENDENT RADIOTHERAPY CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 16. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR CANCER RESEARCH CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 17. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 18. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR CT/CBCT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 19. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR MRI, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 20. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR ULTRASOUND, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 21. GLOBAL FIDUCIAL MARKERS MARKET VALUE FOR RADIOTHERAPY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 22. GLOBAL FIDUCIAL MARKERS MARKET VALUE, BY REGION, 2020-2026 (USD MILLION)
CHART. 23. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 24. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 25. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 26. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 27. NORTH AMERICA FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 28. U.S. FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 29. CANADA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 30. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 31. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 32. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 33. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 34. EUROPE FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 35. GERMANY FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 36. UK FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 37. FRANCE FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 38. ITALY FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 39. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 40. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 41. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 42. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 43. ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
CHART. 44. CHINA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 45. INDIA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 46. JAPAN PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 47. AUSTRALIA FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 48. REST OF ASIA PACIFIC FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 49. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY CANCER TYPE, 2020-2026 (USD MILLION)
CHART. 50. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 51. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY MODALITY, 2020-2026 (USD MILLION)
CHART. 52. REST OF WORLD FIDUCIAL MARKERS MARKET VALUE, BY END-USER, 2020-2026 (USD MILLION)
